NEORNAT
Innovating cancer treatments by targeting RNA to fight cancer at its core.
Enterprise value
$12—18m
Company register number
6368801728
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
KRW3.5b | Series A | ||
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads